Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Resistance in Cancer Therapy and the Role of Epigenetics
Takeshi Asano
Journal of Nippon Medical School (2020) Vol. 87, Iss. 5, pp. 244-251
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Sepideh Mirzaei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 374
Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 156
Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
Hana Q. Sadida, Alanoud Abdulla, Sara Al Marzooqi, et al.
Translational Oncology (2023) Vol. 39, pp. 101821-101821
Open Access | Times Cited: 52
Efficacy and Safety Assessment of Intrathoracic Perfusion Chemotherapy Combined with immunological factor Interleukin-2 in the Treatment of Advanced Non-Small Cell Lung Cancer: A Retrospective Cohort Study
Qiang Cao, Jinyi Zhu, Xinyan Wu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 7, pp. 2024-2032
Open Access | Times Cited: 17
Epigenetic Targets and Their Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
Xiaohui Miao, Pan Liu, Yangyang Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117463-117463
Closed Access | Times Cited: 2
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
Xiangyu Sun, Ping Zhao, Jierou Lin, et al.
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 390-415
Open Access | Times Cited: 31
EZH2-mediated development of therapeutic resistance in cancer
Parminder Kaur, Eswar Shankar, Sanjay Gupta
Cancer Letters (2024) Vol. 586, pp. 216706-216706
Closed Access | Times Cited: 12
Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases
Zhan Wang, Junyi Ren, Jinxiu Du, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16116-16116
Open Access | Times Cited: 31
EZH2: An Accomplice of Gastric Cancer
Wuhan Yu, Ning Liu, Xiaogang Song, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 425-425
Open Access | Times Cited: 22
Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy
Shicai Liu, Jinke Wang
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 6, pp. 2695-2709
Open Access | Times Cited: 26
Drug Resistance in Cancers: A Free Pass for Bullying
Jing Li, Xiao Li, Qie Guo
Cells (2022) Vol. 11, Iss. 21, pp. 3383-3383
Open Access | Times Cited: 23
FNC (4′-azido-2′-deoxy-2′-fluoro(arbino)cytidine) as an Effective Therapeutic Agent for NHL: ROS Generation, Cell Cycle Arrest, and Mitochondrial-Mediated Apoptosis
Naveen Kumar, Alok Shukla, Sanjay Kumar, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 623-639
Closed Access | Times Cited: 6
Sanggenol L induces ferroptosis in non-small cell lung cancer cells via regulating the miR-26a-1-3p/MDM2/p53 signaling pathway
Rong Fu, Yujie You, Yuqing Wang, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116345-116345
Closed Access | Times Cited: 6
Trends in Anti-Tumor Effects of Pseudomonas aeruginosa Mannose-Sensitive-Hemagglutinin (PA-MSHA): An Overview of Positive and Negative Effects
Dragica Božić, Jovana Živanović, Katarina Živančević, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 524-524
Open Access | Times Cited: 5
Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discovery
Mohammad Feyzizadeh, Ashkan Barfar, Zeinab Nouri, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 9, pp. 1013-1027
Closed Access | Times Cited: 21
When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): Progress, potential, and perspective
Zhiqiang Zhang, Chaohui Bao, Jiang Lu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 13
Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
Xiao-Hai Song, Lan Yang, Xiuli Zheng, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 11
Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance
Lixin Li, Y. Hao, Lei Dong, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
Epigenetic Rewiring of Protein Kinase Signalling in T-Cell Acute Lymphoblastic Leukaemia
Claudina Pérez-Novo, Amber Driesen, Maaike Van Trimpont, et al.
Kinases and Phosphatases (2025) Vol. 3, Iss. 2, pp. 7-7
Open Access
HGF/c‐Met Promotes Breast Cancer Tamoxifen Resistance Through the EZH2/HOTAIR‐miR‐141/200a Feedback Signaling Pathway
Xiaofeng Lai, Yuan Zhang, Mengyang Li, et al.
Molecular Carcinogenesis (2025)
Closed Access
Discovery of drug transporter inhibitors tied to long noncoding RNA in resistant cancer cells; a computational model -in silico- study
Mohanad Diab, Amel Hamdi, Feras Al‐Obeidat, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The role of PYCR1 in inhibiting 5-fluorouracil-induced ferroptosis and apoptosis through SLC25A10 in colorectal cancer
Borong Zhou, Zhongchao Mai, Ying Ye, et al.
Human Cell (2022) Vol. 35, Iss. 6, pp. 1900-1911
Closed Access | Times Cited: 16
Effects of Micrornas and Long Non-Coding RNAs on Chemotherapy Response in Glioma
Sara Ahmadpour, Tarannomsadat Taghavi, Amirhossein Sheida, et al.
Epigenomics (2022) Vol. 14, Iss. 9, pp. 549-563
Closed Access | Times Cited: 13
Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma
José A. Peña-Flores, Mercedes Bermúdez, Rosalío Ramos‐Payán, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Vegetal-Derived Bioactive Compounds as Multidrug Resistance Modulators in Colorectal Cancer
Francisco Quiñonero, Cristina Mesas, Mercedes Peña, et al.
Applied Sciences (2023) Vol. 13, Iss. 4, pp. 2667-2667
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top